About Necs Pharma LLP
Data last updated:
Necs Pharma LLP is a limited liability partnership (LLP) based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 September 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAH-4081. Its GSTIN is 27AANFN2174P1ZK (Maharashtra). The LLP holds 2 GST registrations, of which 1 is active.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Rachit Bharat Dave and Sankaranarayanamoorthy Muthukrishnan.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Navi Mumbai, Maharashtra.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹10.5 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹35.64 Lakh (net margin 3.4%) and EBITDA of -₹1.83 Cr (EBITDA margin -17.4%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 107% over five years.
The LLP has about 128 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹4.44 Cr on record. Court records list 16 cases involving the LLP, including 2 filed by the LLP and 14 filed against it; 10 cases are pending.
For more details, the LLP can be reached via its website necspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressFlat No. 201 Plot – 2 Twinkle Co – Op Hsg Sty Sector – 19 Neru, L, Navi Mumbai, Maharashtra, India – 400706
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Necs Pharma LLP FY 2025 filings available
Necs Pharma LLP reported revenue of ₹10.5 Cr (up 251% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Necs Pharma LLP
Revenue has grown at a compounded annual rate (CAGR) of 107% over five years, including 251% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Necs Pharma LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹35.64 Lakh | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Necs Pharma LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 3.4% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Necs Pharma are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Necs Pharma LLP
Necs Pharma has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rachit Bharat Dave | Designated Partner | 16 Sep 2016 | 10 Years 0 Months | Current |
| Sankaranarayanamoorthy Muthukrishnan | Designated Partner | 16 Sep 2016 | 10 Years 0 Months | Current |
Ownership and Shareholding of Necs Pharma LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Necs Pharma LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Feb 2022 | Bank of Baroda | ₹17.24 Lakh | Open |
| 04 May 2020 | Bank of Baroda | ₹10 Lakh | Open |
| 11 Oct 2018 | Bank of Baroda | ₹4.17 Cr | Open |
Total charge records: 3 View all charges
Legal Cases of Necs Pharma LLP
Necs Pharma LLP has 16 court cases on record: 2 filed by Necs Pharma, 14 filed against it. 10 cases are pending and 6 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 16 | 14 | 10 |
Cases on record (5 of 16)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Cases SS) | Filed against the company by Yes Bank Limited | Pending |
| District court, Ludhiana, Punjab | Commercial suit | Filed against the company by Hero Fincorp Limited | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Aarmed Formulations Private Limited | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed against the company by Clix Capital Services Private Limited | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by Dupen Laboratories Private Limited | Pending |
Full case history
All 16 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Necs Pharma LLP
Necs Pharma LLP has a workforce of 78 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Necs Pharma LLP
Necs Pharma LLP has 2 designated partner changes on record since 2016: 2 appointments. The latest: Rachit Bharat Dave was appointed as Designated Partner on 16 Sep 2016.
Credit Ratings, Litigation & Regulatory Alerts for Necs Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Necs Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Necs Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Necs Pharma LLP
Necs Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AANFN2174P1ZK | Maharashtra | Active | 13 Sep 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Necs Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Necs Pharma LLP
Necs Pharma is an active limited liability partnership based in Navi Mumbai, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 16 September 2016 (10+ years old) and is registered under LLPIN AAH-4081.
Necs Pharma reported revenue of ₹10.5 Cr for FY 2023 (up 251% YoY).
Necs Pharma has 2 current designated partners:
- Rachit Bharat Dave - Designated Partner
- Sankaranarayanamoorthy Muthukrishnan - Designated Partner
Necs Pharma reported a net profit of ₹35.64 Lakh (net margin 3.4%) and EBITDA of -₹1.83 Cr (EBITDA margin -17.4%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Necs Pharma is 22% over three years and 107% over five years. In the latest year (FY 2023) revenue rose 251%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Necs Pharma is 27AANFN2174P1ZK, registered in Maharashtra. The LLP has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The LLPIN (Limited Liability Partnership Identification Number) of Necs Pharma is AAH-4081. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Necs Pharma has 16 court cases on record: 2 filed by the LLP and 14 filed against it. 10 are pending.
Necs Pharma was incorporated on 16 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Rachit Bharat Dave was appointed as Designated Partner on 16 Sep 2016. Sankaranarayanamoorthy Muthukrishnan was appointed as Designated Partner on 16 Sep 2016.